Tips

四月美迪西将主办3场线上教育主播，同时参与5场业会议触屏，期待与各位业内同仁交流分享药物研发新趋势。

第6届BIONNOVA生物医药创新者论坛暨展览会

2025年4月9-10日，第6届BIONNOVA菌物医疗改革自主创新者论坛网暨展示出来会邀请新老用户老朋友再者之约广州张江科学课会堂，与10000+菌物医疗全文化产业的发展改革自主创新实践内容者同筑新程!

开运电竞 科技工艺技术工艺食用的口服药学习定性分析部有担当人章登吉硕士生将特邀应邀出席，并在4月9日“免疫抗体偶联食用的口服药学习探索性”社区论坛分享一下：从CRO第三视角看ADC/XDC类食用的口服药研发团队上升趋势及对临床治疗前学习的学习定性分析终极挑战。

美迪西团体将在T02号标摊，等待中您的亲临学习交流！

20th Annual Drug Discovery Chemistry

Optimizing Small Molecules for Tomorrow’s Therapeutics
Medicilon Booth #510

Medicilon offers comprehensive drug discovery services, encompassing medicinal and synthetic chemistry, along with biology expertise. We empower pharmaceutical, biotech, and academic researchers to accelerate small molecule drug candidate discovery and optimization. Leveraging FTE and FFS models, we provide integrated chemistry research services and employ cutting-edge technologies like AI, PROTAC, and ADC technology to efficiently advance projects, control costs, and ensure superior quality.

AACR 2025

Medicilon is excited to exhibit at the AACR Annual Meeting, a premier forum for cancer research advances. Meet Dr. Qingcong Lin, President of Medicilon USA Corp., Dr. Lilly Xu, CTO of Medicilon, and Dr. Baohong Cao, VP of Pharmacology. 

Dr. Weizhong Zhang will present a Medicilon poster on "Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies" on Sunday, April 27, from 2:00 PM-5:00 PM, Poster #26, Section 2.

Join Medicilon at booth #3740 to discuss your research needs. 

Nordic Precision Medicine Forum 2025

Nordic Precision Medicine Forum brings four tracks under one roof. The multi topic forum is dedicated to advancing the diagnosis, prognosis and treatment of disease across the Nordics. Bringing together those leading the move towards more personalised approaches, Nordic Precision Medicine Forum is considered the meeting for the region. Benefiting from insight on Nordic and international initiatives, attendees of Nordic Precision Medicine Forum will have the opportunity to come together, ask questions, problem solve and network with key opinion leaders in Precision Medicine and the fields of oncology and pathology. 

Medicilon is excited to attend and exhibit at the conference. Dr. Paul G.J. van Stralen, VP Strategic Collaborations EMEA at Medicilon, will be available at the conference. We look forward to greeting you in Stockholm! 

18th Drug Discovery Strategic Summit

18th Drug Discovery Strategic Summit (DDSS) is designed to ignite business innovation and foster progress. Grounded in deep industry expertise and shaped by client insights. Where Innovation Meets Opportunity: Exclusive Summits for Drug Discovery Leaders. Medicilon will exhibit at the 18th DDSS. Medicilon's drug discovery services integrate chemistry and biology, offering custom synthesis, compound library construction, SAR compound synthesis and screening, and compound structure and biological activity optimization. Our medicinal chemistry team utilizes computational chemistry to enhance compound design and incorporates advanced technologies to efficiently deliver high-quality results while controlling costs.

marketing@czchengteng.com
媒体与会务请联系
美迪西市场部微信或邮箱